Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...
Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...
Medicare serves as a crucial healthcare safety net for many Americans, yet it is not without its limitations. In 2026, beneficiaries must be vigilant about the gaps in coverage that could lead to ...
In 2026, Medicare continues to be a vital resource for many, yet it is crucial to recognize its limitations. While it covers hospitalizations, doctor visits, and some essential treatments, there are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results